Hb Wealth Management, LLC Candel Therapeutics, Inc. Transaction History
Hb Wealth Management, LLC
- $12.3 Billion
- Q2 2025
Shares
3 transactions
Others Institutions Holding CADL
# of Institutions
84Shares Held
15.3MCall Options Held
570KPut Options Held
203K-
Acorn Capital Advisors, LLC New York, NY2.58MShares$12.7 Million8.54% of portfolio
-
Northpond Ventures, LLC1.94MShares$9.52 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$8.79 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.62MShares$7.98 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA904KShares$4.45 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $142M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...